Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epirubicin, Carboplatin & Capecitabine in Adult Cancer Patients
NCT00021047Phase 2Completed
- Sponsor
- National Institutes of Health
- Start
- Jul 2001
- Modality
- DNA Intercalators/Alkylators, Irreversible Covalent Inhibitors, RNA-Targeting Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capecitabine in solid tumor, head and neck cancer (HNC), esophageal cancer, gastric cancer (GC), hepatobiliary cancer (HBC), sponsored by National Institutes of Health. Started Jul 2001; status: completed.
02
Drugs
capecitabine
03
Conditions
solid tumorhead and neck cancer (HNC)esophageal cancergastric cancer (GC)hepatobiliary cancer (HBC)
Beyond the preview
Go deeper on NCT00021047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00021047.